Sao Tome and Principe Health Report
SEE OTHER BRANDS

Keeping up with health and wellness news from Sao Tome and Principe

Sao Tome and Principe Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sao Tome and Principe Health Report.

Press releases published on October 14, 2025

BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Assembly Biosciences Announces Upcoming Investor Conference Participation
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
Iantrek Announces Commercial Launch of AlloFlo™ Uveo, the Only Surgical Treatment Targeting the Uveoscleral Pathway in Glaucoma
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
Soleo Health Introduces State-of-the-Art Pharmacy and Infusion Center in Washington, D.C., Area
Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems
BCC Research Forecasts 7.5% CAGR for Pen Needles Market Through 2030
Abalos Therapeutics Publishes in Cell Reports Medicine  Validating ABX-001’s Potential to Overcome Cancer Immunotherapy Hurdles
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
AB Science will hold a virtual conference on Thursday, October 16, 2025  from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions